A 00612 (see companion bill S 02391) – New York
Introduced: 2019 Status: Inactive / Dead
Requires the commissioner of health to establish and publish a list of generic drug products.
A 01924 – New York
Introduced: 2019 Status: Inactive / Dead
Authorizes a pharmacist to substitute a brand name prescription drug for the generic equivalent of such drug if requested to do so by the patient and record the request.
A 02007 (see companion bill S 01507) – New York
Introduced: 2019 Status: Enacted Year Enacted: 2019
Enacts into law major components of legislation necessary to implement the state health and mental hygiene budget for the 2019-2020 state fiscal year; extends and enhances the Medicaid drug cap and reduces unnecessary pharmacy benefit …
A 02783 – New York
Introduced: 2019 Status: Inactive / Dead
Provides for increasing the applicability of brand name and generic prescription drugs and other medical services, except diagnostic services, co-payments for medicaid recipients.
A 02795 (see companion bill S 05923) – New York
Introduced: 2019 Status: Inactive / Dead
Extends the preferred drug program to medicaid managed care providers and offers the program to other health plans.
A 02799 (see companion bill S 01794) – New York
Introduced: 2019 Status: Inactive / Dead
Provides for coverage for certain medically necessary prescription drugs in Medicaid managed care programs.
A 02836 (see companion bills S 02087 and S 06531) – New York
Introduced: 2019 Status: Inactive / Dead
Provides for pharmacy benefit management and the procurement of prescription drugs to be dispensed to patients, or the administration or management of prescription drug benefits; sets forth definitions; provides for funds received by a pharmacy …
A 02843 – New York
Introduced: 2019 Status: Inactive / Dead
Requires Medicaid managed care, and Child Health Plus plans to adopt the procedural protections of the Preferred Drug Program, including “prescriber prevails,” for all drugs.
A 02969 (see companion bill S 02849) – New York
Introduced: 2019 Status: Inactive / Dead
AN ACT to amend the insurance law and the public health law, in relation to prescription drug formulary changes during a contract year to allow formulary changes mid-year if a generic equivalent is released.
A 02970 (see companion bill S 01705) – New York
Introduced: 2019 Status: Inactive / Dead
Implements the pharmacy benefit manager transparency act requiring disclosure and publishing of reports relating to pharmacy benefit managers.
A 03038 (see companion bill S 02847) – New York
Introduced: 2019 Status: Inactive / Dead
Relates to utilization review program standards; requires use of evidence-based and peer reviewed clinical review criteria; amends provisions relating to prescription drug formulary changes and pre-authorization for certain health care services.
A 03043 (see companion bill S 04463) – New York
Introduced: 2019 Status: Inactive / Dead
Relates to the purchase of prescription drugs.
A 03048 – New York
Introduced: 2019 Status: Inactive / Dead
Includes nurse practioners as a provider of services for purposes of collaborative drug therapy management and makes the authorization for pharmacists to perform such management permanent.
A 03273 – New York
Introduced: 2015 Status: Inactive / Dead
DRUG TIERS: would require the Superintendent of the Insurance Department to deny policies that impose drug tiers that are based on expense or disease. It would also require the superintendent to deny polices that charge …
A 03829 (see companion bill S 01798 – New York
Introduced: 2019 Status: Inactive / Dead
Prohibits price gouging by manufacturers of prescription drugs.
A 04521 – New York
Introduced: 2019 Status: Inactive / Dead
Relates to access to appropriate drugs at reasonable prices, formulary exceptions, standing prior authorizations and external appeals; to access to retail pharmacies, prescription synchronization, limits on patient drug costs, explanations of benefits and rebates; to …